USANA Health Sciences, Inc. (NYSE:USNA) Short Interest Up 19.0% in January

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 578,100 shares, a growth of 19.0% from the January 15th total of 485,900 shares. Based on an average trading volume of 113,600 shares, the short-interest ratio is currently 5.1 days. Approximately 5.2% of the shares of the company are sold short.

USANA Health Sciences Trading Down 0.7 %

Shares of NYSE:USNA traded down $0.22 during midday trading on Wednesday, hitting $31.19. The stock had a trading volume of 80,104 shares, compared to its average volume of 127,314. The company has a market capitalization of $594.50 million, a PE ratio of 11.01, a P/E/G ratio of 0.85 and a beta of 0.87. USANA Health Sciences has a 1 year low of $30.13 and a 1 year high of $50.32. The stock has a 50 day moving average price of $34.29 and a two-hundred day moving average price of $36.97.

Institutional Investors Weigh In On USANA Health Sciences

Institutional investors have recently added to or reduced their stakes in the business. Barclays PLC lifted its holdings in shares of USANA Health Sciences by 111.9% in the 3rd quarter. Barclays PLC now owns 27,737 shares of the company's stock valued at $1,052,000 after buying an additional 14,647 shares during the period. Allspring Global Investments Holdings LLC raised its position in USANA Health Sciences by 14,068.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company's stock worth $1,472,000 after acquiring an additional 38,547 shares in the last quarter. Assenagon Asset Management S.A. lifted its holdings in USANA Health Sciences by 13.5% in the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company's stock valued at $4,702,000 after acquiring an additional 14,756 shares during the period. Geode Capital Management LLC boosted its position in shares of USANA Health Sciences by 4.5% during the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company's stock worth $11,269,000 after purchasing an additional 12,898 shares in the last quarter. Finally, State Street Corp grew its stake in shares of USANA Health Sciences by 0.6% during the 3rd quarter. State Street Corp now owns 435,164 shares of the company's stock worth $16,501,000 after purchasing an additional 2,782 shares during the period. Hedge funds and other institutional investors own 54.25% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of analysts have weighed in on USNA shares. StockNews.com cut USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. DA Davidson increased their price target on USANA Health Sciences from $35.00 to $38.00 and gave the stock a "neutral" rating in a report on Thursday, January 2nd.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.